UK markets close in 8 hours 14 minutes

Fresenius Medical Care AG & Co. KGaA (FMS)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
22.59-0.50 (-2.17%)
At close: 04:00PM EDT
23.10 +0.51 (+2.26%)
After hours: 07:41PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in EUR. All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
595,625
673,000
969,000
1,164,000
1,200,000
Depreciation & amortisation
1,868,661
1,838,363
1,623,676
1,786,000
1,593,000
Deferred income taxes
-36,866
-41,471
67,259
111,104
64,266
Stock-based compensation
-
-
0
0
1,992
Change in working capital
242,329
-566,000
-354,000
1,012,000
-465,000
Accounts receivable
-51,820
-46,682
-163,197
71,695
-64,111
Inventory
-196,643
-204,307
-48,530
-355,831
-117,504
Accounts payable
-81,706
-356,789
-363,955
1,373,617
-164,767
Other working capital
1,719,989
756,000
806,000
2,145,000
329,000
Other non-cash items
314,915
1,838,000
1,624,000
1,786,000
1,593,000
Net cash provided by operating activities
2,407,248
2,167,000
2,489,000
4,233,000
2,567,000
Cash flows from investing activities
Investments in property, plant and equipment
-687,259
-1,411,000
-1,683,000
-2,088,000
-2,238,000
Acquisitions, net
-12,544
-59,000
-434,000
-259,000
-2,233,000
Purchases of investments
-82,306
-106,000
-129,000
-96,000
-2,173,000
Sales/maturities of investments
81,389
58,000
144,000
42,000
-
Net cash used for investing activities
-622,359
-734,725
-1,196,228
-1,334,942
-3,285,987
Cash flows from financing activities
Debt repayment
-2,132,682
-2,822,023
-3,407,204
-4,181,723
-4,160,866
Common stock repurchased
-
0
0
-365,988
-599,796
Dividends paid
-328,623
-395,556
-392,455
-351,170
-354,636
Other financing activities
-424,978
-123,950
-279,535
-693,531
153,387
Net cash used provided by (used for) financing activities
-1,322,993
-1,617,360
-1,024,382
-2,664,027
-466,633
Net change in cash
336,626
-207,868
400,116
73,816
-1,137,909
Cash at beginning of period
1,024,672
1,481,655
1,081,539
1,007,723
2,145,632
Cash at end of period
1,486,568
1,273,787
1,481,655
1,081,539
1,007,723
Free cash flow
Operating cash flow
2,407,248
2,167,000
2,489,000
4,233,000
2,567,000
Capital expenditure
-687,259
-1,411,000
-1,683,000
-2,088,000
-2,238,000
Free cash flow
1,719,989
756,000
806,000
2,145,000
329,000